lower back pain on glp 1 Does GLP-1 cause pain? Side effects explained GLP-1 Drugs and Muscle Loss:

Article 43

It has been structurally modified to resist dipeptidyl peptidase-4 (DPP-4) degradation and to enhance albumin binding, extending its half-life to approximately 165 hours

-1.02, -0.28) for intravesical injection

Soft Tissue Recovery : Research examines potential effects on muscle, tendon, and ligament healing, which relates to recovery from strains and overuse injuries

Several important considerations apply: Individuals with active or severe gastrointestinal disease may experience worsening symptoms due to the gastrointestinal side effects of GLP-1 medications The slowed gastric emptying caused by these drugs could theoretically exacerbate symptoms in people with strictures or obstructive complications of Crohn's disease Weight loss associated with GLP-1 therapy may be inappropriate in patients with Crohn's disease who are already experiencing malnutrition or unintentional weight loss The interaction between GLP-1 medications and the inflammatory processes in IBD is not fully understood Clinical decision-making should involve a thorough assessment of disease activity, nutritional status, presence of complications (such as strictures or fistulas), and the primary indication for GLP-1 therapy